AcquisitionFinTech

LUMOS PHARMA, INC. acquired target

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

LUMOS PHARMA, INC. -> target · $4.25

Following a thorough review of financing and strategic alternatives, Lumos Pharma’s Board of Directors (the “Board”), with the assistance of the Board’s legal and financial advisors, unanimously determined that the acquisition by DPV is in the best interests o

Open source record (SEC) ↗